TRVI Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | Galletta Christopher | officer: See Remarks | 28,500 | A-Award | A | 28,500 | 2.38 | 67,830.00 |
| 2024-02-15 | Simon Farrell | officer: Chief Commercial Officer | 175,000 | A-Award | A | 175,000 | 2.38 | 416,500.00 |
| 2024-02-15 | Clark David J | officer: Chief Medical Officer | 175,000 | A-Award | A | 175,000 | 2.38 | 416,500.00 |
| 2024-02-15 | GOOD JENNIFER L | director, officer: President & CEO | 630,000 | A-Award | A | 630,000 | 2.38 | 1,499,400.00 |
| 2024-02-15 | SCIASCIA THOMAS | officer: Chief Scientific Officer | 150,000 | A-Award | A | 150,000 | 2.38 | 357,000.00 |
| 2024-02-15 | Delfini Lisa | officer: Chief Financial Officer | 175,000 | A-Award | A | 175,000 | 2.38 | 416,500.00 |
| 2023-10-11 | Delfini Lisa | officer: Chief Financial Officer | 64,168 | M-Exempt | D | 2,292 | 0.51 | 1,171.00 |
| 2023-10-11 | Delfini Lisa | officer: Chief Financial Officer | 36,686 | M-Exempt | A | 2,292 | 0.51 | 1,171.00 |
| 2023-10-11 | Delfini Lisa | officer: Chief Financial Officer | 35,901 | S-Sale | D | 785 | 2.02 | 1,586.00 |
| 2023-09-11 | Delfini Lisa | officer: Chief Financial Officer | 66,460 | M-Exempt | D | 2,291 | 0.51 | 1,171.00 |
| 2023-09-11 | Delfini Lisa | officer: Chief Financial Officer | 35,105 | M-Exempt | A | 2,291 | 0.51 | 1,171.00 |
| 2023-09-11 | Delfini Lisa | officer: Chief Financial Officer | 34,394 | S-Sale | D | 711 | 2.20 | 1,564.00 |
| 2023-08-11 | Delfini Lisa | officer: Chief Financial Officer | 68,751 | M-Exempt | D | 2,292 | 0.51 | 1,171.00 |
| 2023-08-11 | Delfini Lisa | officer: Chief Financial Officer | 33,496 | M-Exempt | A | 2,292 | 0.51 | 1,171.00 |
| 2023-08-11 | Delfini Lisa | officer: Chief Financial Officer | 32,814 | S-Sale | D | 682 | 2.36 | 1,610.00 |
| 2023-07-11 | Delfini Lisa | officer: Chief Financial Officer | 71,043 | M-Exempt | D | 2,292 | 0.51 | 1,171.00 |
| 2023-07-11 | Delfini Lisa | officer: Chief Financial Officer | 31,891 | M-Exempt | A | 2,292 | 0.51 | 1,171.00 |
| 2023-07-11 | Delfini Lisa | officer: Chief Financial Officer | 31,204 | S-Sale | D | 687 | 2.34 | 1,608.00 |
| 2023-06-28 | Mathers Edward T | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-28 | Cassella James V | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-28 | Heffernan Michael Thomas | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-28 | Meeker David P | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-28 | Colangelo Dominick | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-28 | VANLENT ANNE | director | 30,000 | A-Award | A | 30,000 | 2.27 | 68,100.00 |
| 2023-06-20 | Simon Farrell | officer: Chief Commercial Officer | 50,000 | M-Exempt | D | 6,250 | 0.51 | 3,194.00 |
| 2023-06-20 | Simon Farrell | officer: Chief Commercial Officer | 45,650 | M-Exempt | A | 6,250 | 0.51 | 3,194.00 |
| 2023-06-12 | Delfini Lisa | officer: Chief Financial Officer | 73,335 | M-Exempt | D | 2,291 | 0.51 | 1,171.00 |
| 2023-06-12 | Delfini Lisa | officer: Chief Financial Officer | 30,209 | M-Exempt | A | 2,291 | 0.51 | 1,171.00 |
| 2023-06-12 | Delfini Lisa | officer: Chief Financial Officer | 29,599 | S-Sale | D | 610 | 2.64 | 1,610.00 |
| 2023-05-11 | Delfini Lisa | officer: Chief Financial Officer | 75,626 | M-Exempt | D | 2,291 | 0.51 | 1,171.00 |
| 2023-05-11 | Delfini Lisa | officer: Chief Financial Officer | 28,480 | M-Exempt | A | 2,291 | 0.51 | 1,171.00 |
| 2023-05-11 | Delfini Lisa | officer: Chief Financial Officer | 27,918 | S-Sale | D | 562 | 2.89 | 1,624.00 |
| 2023-04-11 | Delfini Lisa | officer: Chief Financial Officer | 77,917 | M-Exempt | D | 2,292 | 0.51 | 1,171.00 |
| 2023-04-11 | Delfini Lisa | officer: Chief Financial Officer | 27,029 | M-Exempt | A | 2,292 | 0.51 | 1,171.00 |
| 2023-04-11 | Delfini Lisa | officer: Chief Financial Officer | 26,189 | S-Sale | D | 840 | 1.84 | 1,545.00 |
| 2023-03-13 | Delfini Lisa | officer: Chief Financial Officer | 80,209 | M-Exempt | D | 2,291 | 0.51 | 1,171.00 |
| 2023-03-13 | Delfini Lisa | officer: Chief Financial Officer | 25,629 | M-Exempt | A | 2,291 | 0.51 | 1,171.00 |
| 2023-03-13 | Delfini Lisa | officer: Chief Financial Officer | 24,737 | S-Sale | D | 892 | 1.75 | 1,564.00 |
| 2023-03-07 | Simon Farrell | officer: Chief Commercial Officer | 56,250 | M-Exempt | D | 18,750 | 0.51 | 9,581.00 |
| 2023-03-07 | Simon Farrell | officer: Chief Commercial Officer | 39,400 | M-Exempt | A | 18,750 | 0.51 | 9,581.00 |
| 2023-02-16 | Galletta Christopher | officer: See Remarks | 40,000 | A-Award | A | 40,000 | 2.67 | 106,800.00 |
| 2023-02-16 | Simon Farrell | officer: Chief Commercial Officer | 100,000 | A-Award | A | 100,000 | 2.67 | 267,000.00 |
| 2023-02-16 | Simon Farrell | officer: Chief Commercial Officer | 20,650 | D | 0 | 0.00 | 0.00 | |
| 2023-02-16 | Simon Farrell | officer: Chief Commercial Officer | 0 | D | 75,000 | 3.91 | 293,250.00 | |
| 2023-02-16 | Simon Farrell | officer: Chief Commercial Officer | 0 | D | 17,500 | 3.21 | 56,175.00 | |
| 2023-02-16 | Simon Farrell | officer: Chief Commercial Officer | 0 | D | 75,000 | 0.51 | 38,325.00 | |
| 2023-02-16 | SCIASCIA THOMAS | officer: Chief Scientific Officer | 187,500 | A-Award | A | 187,500 | 2.67 | 500,625.00 |
| 2023-02-16 | Delfini Lisa | officer: Chief Financial Officer | 187,500 | A-Award | A | 187,500 | 2.67 | 500,625.00 |
| 2023-02-16 | GOOD JENNIFER L | director, officer: President & CEO | 375,000 | A-Award | A | 375,000 | 2.67 | 1,001,250.00 |
| 2023-02-13 | Delfini Lisa | officer: Chief Financial Officer | 82,500 | M-Exempt | D | 27,500 | 0.51 | 14,052.00 |
| 2023-02-13 | Delfini Lisa | officer: Chief Financial Officer | 31,812 | M-Exempt | A | 27,500 | 0.51 | 14,052.00 |
| 2023-02-13 | Delfini Lisa | officer: Chief Financial Officer | 23,338 | S-Sale | D | 8,474 | 2.45 | 20,761.00 |
| 2022-11-14 | Clark David J | officer: Chief Medical Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2022-11-14 | Clark David J | None | 0 | None | None | 0.00 | ||
| 2022-11-14 | Clark David J | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2022-09-19 | SCIASCIA THOMAS | officer: Chief Medical Officer | 37,500 | A-Award | A | 7,500 | 3.21 | 24,075.00 |
| 2022-09-19 | GOOD JENNIFER L | director, officer: President & CEO | 160,000 | A-Award | A | 32,000 | 3.21 | 102,720.00 |
| 2022-07-01 | TPG GP A, LLC | other: Former 10% Owner | 3,888,452 | S-Sale | D | 436,431 | 2.86 | 1,246,185.00 |
| 2022-07-01 | WINKELRIED JON | director: | 3,824,883 | S-Sale | D | 63,569 | 3.11 | 197,827.00 |
| 2022-07-05 | TPG GP A, LLC | other: Former 10% Owner | 3,824,883 | S-Sale | D | 63,569 | 3.11 | 197,827.00 |
| 2022-06-23 | VANLENT ANNE | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-23 | Meeker David P | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-23 | Heffernan Michael Thomas | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-23 | Colangelo Dominick | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-23 | Cassella James V | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-29 | SCIASCIA THOMAS | officer: Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-29 | Forbes William P | officer: Chief Development Officer | 48,000 | A-Award | A | 48,000 | 0.00 | 0.00 |
| 2022-06-29 | Forbes William P | officer: Chief Development Officer | 48,000 | A-Award | A | 48,000 | 3.21 | 154,080.00 |
| 2022-06-29 | GOOD JENNIFER L | officer: President & CEO | 128,000 | A-Award | A | 128,000 | 0.00 | 0.00 |
| 2022-06-29 | GOOD JENNIFER L | director, officer: President & CEO | 128,000 | A-Award | A | 128,000 | 3.21 | 410,880.00 |
| 2022-02-11 | SCIASCIA THOMAS | officer: Chief Medical Officer | 110,000 | A-Award | A | 110,000 | 0.51 | 56,210.00 |
| 2022-02-11 | Forbes William P | officer: Chief Development Officer | 137,500 | A-Award | A | 137,500 | 0.51 | 70,262.00 |
| 2022-02-14 | GOOD JENNIFER L | director, officer: President & CEO | 275,000 | A-Award | A | 275,000 | 0.51 | 139,508.00 |
| 2022-06-29 | WINKELRIED JON | director: | 4,754,721 | S-Sale | D | 46,128 | 2.74 | 126,303.00 |
| 2022-06-29 | TPG GP A, LLC | 10 percent owner | 4,754,721 | S-Sale | D | 46,128 | 2.74 | 126,303.00 |
| 2022-06-30 | TPG GP A, LLC | 10 percent owner | 4,324,883 | S-Sale | D | 429,838 | 2.77 | 1,191,898.00 |
| 2022-06-23 | Mathers Edward T | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-23 | Mathers Edward T | director | 20,000 | A-Award | A | 20,000 | 2.27 | 45,400.00 |
| 2022-06-23 | VANLENT ANNE | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-23 | Meeker David P | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-23 | Heffernan Michael Thomas | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-23 | Colangelo Dominick | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-23 | Cassella James V | director: | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-05-02 | WINKELRIED JON | director: | 4,800,849 | S-Sale | D | 600 | 2.70 | 1,620.00 |
| 2022-05-02 | TPG GP A, LLC | 10 percent owner | 4,800,849 | S-Sale | D | 600 | 2.70 | 1,620.00 |
| 2022-04-28 | TPG GP A, LLC | 10 percent owner | 4,817,612 | S-Sale | D | 7,271 | 2.77 | 20,140.00 |
| 2022-04-28 | WINKELRIED JON | director: | 4,801,449 | S-Sale | D | 16,163 | 2.75 | 44,385.00 |
| 2022-04-29 | TPG GP A, LLC | 10 percent owner | 4,801,449 | S-Sale | D | 16,163 | 2.75 | 44,385.00 |
| 2022-04-11 | Mathers Edward T | director: | 3,000,000 | A-Award | A | 3,000,000 | 1.90 | 5,697,000.00 |
| 2022-04-11 | Mathers Edward T | director | 3,000,000 | A-Award | A | 3,000,000 | 0.00 | 3,000.00 |
| 2022-04-11 | Mathers Edward T | director | 948,948 | A-Award | A | 948,948 | 1.90 | 1,803,001.00 |
| 2022-04-11 | Walker Paul Edward | director: | 3,000,000 | P-Purchase | A | 3,000,000 | 1.90 | 5,697,000.00 |
| 2022-04-11 | Sonsini Peter W. | director: | 948,948 | P-Purchase | A | 948,948 | 1.90 | 1,803,001.00 |
| 2022-04-11 | SANDELL SCOTT D | 10 percent owner | 10,421,428 | P-Purchase | A | 2,631,578 | 1.90 | 4,999,998.00 |
| 2022-04-11 | SANDELL SCOTT D | director: | 3,000,000 | P-Purchase | A | 3,000,000 | 1.90 | 5,697,000.00 |
| 2022-04-11 | SANDELL SCOTT D | 10 percent owner | 3,000,000 | P-Purchase | A | 3,000,000 | 0.00 | 3,000.00 |
| 2022-04-11 | SANDELL SCOTT D | 10 percent owner | 948,948 | P-Purchase | A | 948,948 | 1.90 | 1,803,001.00 |
| 2022-04-11 | Makhzoumi Mohamad | director: | 10,421,428 | P-Purchase | A | 2,631,578 | 1.90 | 4,999,998.00 |
| 2022-04-11 | Makhzoumi Mohamad | 10 percent owner | 3,000,000 | P-Purchase | A | 3,000,000 | 0.00 | 3,000.00 |
| 2022-04-11 | Makhzoumi Mohamad | 10 percent owner | 948,948 | P-Purchase | A | 948,948 | 1.90 | 1,803,001.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
